Abstract
Breast cancer is known to have a strong familial component, consistent in some families with autosomal dominant inheritance. It has been estimated that approximately 5% of breast cancers may be the result of a highly penetrant autosomal dominant gene (Claus et al., 1991). Such individuals tend to develop breast cancer at an early age, have a high prevalence of bilaterality and are at an elevated risk of other neoplasms (Lynch and Hirayam, 1989). Recently the location of a gene predisposing to both breast and ovarian cancer on chromosome 17q (BRCA1) has been established by genetic linkage analysis (Hall et al., 1990). In an analysis of 214 breast cancer families worldwide, the proportion of families linked to this locus was estimated to be 100% for breast-ovarian cancer families and 45% for families with multiple cases of breast cancer only (Easton et al., 1993). Among breast cancer families without cases of ovarian cancer, a small minority have features of the Li-Fraumeni syndrome (sarcomas in children associated with early onset breast cancer in female relatives) and a proportion of these families are associated with germline mutations in the p53 gene on chromosome 17p (Malkin et al., 1990).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borresen A-L, Andersen TI, Treti S, Heiberg A and Moller P (1990) Breast Cancer and other Cancers in Norwegian Families with Ataxia-Telangiectasia. Genes Chrom. Cancer 2: 339–340
Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48: 232–241
Easton DF, Bishop DT, Ford D, Crockford GT and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer — results from 214 families. (1993) Am. J. Hum. Genet. in press.
Easton DF, and Peto J (1990) The contribution of inherited and predisposition to cancer incidence. Cancer Surveys 9: 395–416.
Foroud T, Wei S, Ziv Y, Sobel E, Lange E, Chao A, Goradia T, Huo Y, Tolun A, Chessa L, Charmley P, Sanai O, Salman N, Julier C, Concannon P, McConville C, Taylor AMR, Shiloh Y, Lange K, Gatti RA (1991) Localisation of an Ataxia-Telangiectasia locus to a 3 cM interval on chromosome 11q23: Linkage analysis of 111 families by an International Consortium. Am J Hum Genet 49: 1263–1279.
Hall JM, Lee MK, Newman B, Morrow J, Anderson L, Huey B and King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689.
Lathrop GM, Lalouel JM, Julier C and Ott J (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81: 3443–3446
Lynch HT and Hirayama T (1989) Genetic epidemiology of cancer. CRC Press Inc., Boca Raton, Florida.
Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer sarcomas and other neoplasms. Science, 250: 1233–1238.
Morrell D, Chase CL and Swift M (1990) Cancer in 44 families with Ataxia-Telangiectasia. Cancer Genet Cytogenet 50: 119–123.
Pippard EC, Hall AJ, Barker JP and Bridges BA (1988) Cancer in homozygotes and heterozygotes of Ataxia-Telangiectasia and Xeroderma Pigmentosum in Britain. Cancer Res 48: 2929–2932.
Swift M, Sholman L, Perry M and Chase CL (1976) Malignant neoplasms in the families of patients with Ataxia-Telangiectasia. Cancer Res 36: 209–215.
Swift M, Morrell D, Cromartie E, Chamberlain AR, Skolnick MH and Bishop DT (1986) The incidence and gene frequency of Ataxia-Telangiectasia in the United States. Am J Hum Genet 39: 573–583.
Swift M, Reitnauer PJ, Morrell D and Chase CL (1987) Breast and other cancers in families with Ataxia-Telangiectasia. New Engl J Med 316: 1289–1294.
Swift M, Morrell D, Massey RB and Chase CL (1991) Incidence of cancer in 161 families affected by Ataxia-Telangiectasia. New Engl J Med. 3 25: 1831–1836.
Warren W, Eeles RA, Ponder BAJ, Easton DF, Averill D, Ponder MA, Anderson K, deMars R, Love R, Dundas S, Stratton MR, Trowbridge P, Cooper CS and Peto J (1992) No evidence for germline mutations in exons 5–9 of the p53 gene in 25 breast cancer families. Oncogene 7: 1043–1046.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wooster, R. et al. (1993). The A-T gene does not make a major contribution to familial breast cancer. In: Gatti, R.A., Painter, R.B. (eds) Ataxia-Telangiectasia. NATO ASI Series, vol 77. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78278-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-78278-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78280-0
Online ISBN: 978-3-642-78278-7
eBook Packages: Springer Book Archive